Esomeprazole and omeprazole could possibly raise the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to increased adverse effects including drowsiness, although the medical relevance is lower for most patients – watch the affected individual for adverse effects (e.If affected individual can not resume their standard oral

Esomeprazole and omeprazole could possibly improve the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) resulting in improved adverse effects for instance drowsiness, although the clinical relevance is small in the majority of sufferers – keep track of the patient for adverse effects (e.If affected individual are not able to